591 filings
Page 10 of 30
6-K
ckpyvxnre2
21 Jul 16
Current report (foreign)
12:00am
6-K
dq32tba
7 Jul 16
Fda Clears Biohaven's Ind for BHV-4157 Ans Portage to Hold Investor Conference Call
12:00am
6-K
rmh13
26 May 16
Portage Announces Orphan Drug Designation Request Granted Fto Biohaven for BHV 4157
12:00am
6-K
o56stlx ku5
27 Apr 16
Biohaven Appoints Chief Commercial Officer
12:00am
6-K
y1yu3
7 Apr 16
Portage Provides Corporate Updates
12:00am
6-K
pst3soy
23 Mar 16
Portage Invests Further In Biohaven
12:00am
6-K
am6utgw
21 Mar 16
Orphan Drug Designation Received by Biohaven
12:00am
6-K
ihrtzhew
14 Mar 16
Announcement of Proposed Private Placement
12:00am
6-K
2xx jopyp
26 Feb 16
Third Quarter 16 Financials and Mda
12:00am
6-K
r43d 2q1vh
25 Feb 16
Expedited Development Path for BHV 0223 for Biohaven
12:00am
6-K
q7slgj4c48btxl0a
25 Feb 16
Positive Results from Phase 1 Study with BHV-0223
12:00am
6-K
erk47f7
8 Feb 16
Notice of Record and Mailing Date
12:00am
6-K
pmwepez0
25 Jan 16
Portage Provides PPL Updates
12:00am
6-K
e6brcw
1 Dec 15
Interim Financials for the Six Months Ended Sept 30, 2015
12:00am
6-K
auw7h77e 4s
23 Nov 15
Biohaven Phase 1 Trials
12:00am
6-K
anq13xhvx kkd
6 Oct 15
Biohaven Completes Multiple Dosing In Phase One Trial
12:00am
6-K
5sv45 wne5v5v2bu8n
2 Oct 15
Strategic Alliance with Fox Chase Chemical
12:00am
6-K
tt7la68l08i7z37grd5m
21 Sep 15
Biohaven Completes Single Dose Phase
12:00am
6-K
wqirv
21 Sep 15
Portage Issues Letter to Shareholders
12:00am